Form 4 for TRVI Trevi Therapeutics, Inc.
Accepted 2025-03-26 00:00:00 ET · period of report 2025-03-25 · accession 0000950170-25-045295 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-26 | 2025-03-25 | TRVI | SCIASCIA THOMAS | CSO | S - Sale+OE | $6.60 | -2,631 | 221.4K | -1% | -$17.4K |
| D | 2025-03-26 | 2025-03-25 | TRVI | SCIASCIA THOMAS | CSO | M - OptEx | $1.43 | +2,631 | 224.0K | +1% | +$3,762 |
| D | 2025-03-26 | 2025-03-25 | TRVI | SCIASCIA THOMAS | CSO | M - OptEx | $0.00 | -2,631 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-25 | S | D | 2,631 | $6.60 | 221,373 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-25 | M | A | 2,631 | $1.43 | 224,004 | D | — | — | (F1) Includes 1,058 shares purchased through the Issuer's employee stock purchase plan. |
| 3 | Derivative | Stock Option (right to buy) | 2025-03-25 | M | D | 2,631 | $0.00 | 0 | D | $1.43 · — to 2025-05-14 | 2,631 Common Stock | (F2) This option was granted on May 15, 2015. The 2,631 shares of common stock underlying the option vested as to 25% of the shares on May 15, 2016 and vested as to the remaining 75% of the shares in equal monthly installments thereafter through May 15, 2019. |